Overview
Properties
Constituents: 10% Trehalose, 1% Human serum albumin
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab83995 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| SDS-PAGE | |
| Functional Studies |
SDS-PAGE: Use at an assay dependent dilution.
Molecular Mass: ab83995 migrates as a band between 15 and 20 kDa in SDS-PAGE. This compares with the predicted molecular mass of 18.7 kDa.
pI: ab83995 separates into a number of isoforms with a pI between 5.4 and 6.0 in 2D PAGE due to post-translational modifications, in particular glycosylation. This compares with the unmodified G-CSF that has a predicted pI of 5.65.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Protein info
-
Alternative names
- Colony stimulating factor 3 (granulocyte)CSF 3CSF beta
- CSF3CSF3_HUMANCsfgFilgrastimG-CSFGCSAGCSFGranulocyte colony stimulating factorGranulocyte colony-stimulating factorLenograstimMacrophage granulocyte inducer 2MGC45931MGI 2Pluripoietin
see all
modificationsO-glycan consists of Gal-GalNAc disaccharide which can be modified with up to two sialic acid residues (done in recombinantly expressed G-CSF from CHO cells).
Target information above from: UniProt accession
P09919
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
References for G-CSF protein (Active) (ab83995)
ab83995 has not yet been referenced specifically in any publications.